
ASX Health Quarterly Wrap: Neurizon turns up the dial on ALS drug progress
'This one goes to 11': Neurizon is making great strides with NUZ-001 and aims to dial it up further. Pic via Getty Images The latest quarterly reporting season is underway, with investors tuning in to see how ASX-listed companies performed during …